Physician profile

Lowell S Weil

Foot & Ankle Surgery · Des Plaines, IL

NPI 1023016623

$43,012.31

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,500.00
Royalty Or License$512.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimmer Biomet Holdings, INC. $18,023.29 2019-2024 Comprehensive Vault Reconstruction System
Ossio INC $8,500.00 2023
Stryker Corporation $8,355.75 2019-2022
Wright Medical Technology, INC. $6,431.14 2019-2020
Smith+Nephew, INC. $1,475.00 2022
Novastep INC. $118.05 2021
Abbott Laboratories $92.85 2019
Ethicon US, LLC $16.23 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lowell S Weil

$43,012.31

in general payments reported 2019-2025

Years
2019-2024
Top company
Zimmer Biomet Holdings, INC.

https://glasscript.com/doctor/273236/lowell-s-weil

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.